Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 21886824 | HLA-DRB1*07 | co-infection | NA | NA | NA | positive | |
| age increased by year, body mass index <16.0, hiv co-infection and the increased number of hla-drb1*0701 allele that patients bear showed significant associations with igra negativity (or = 1.04 [95% ci, 1.01-1.07], 5.42 [1.48-19.79], 6.38 [1.78-22.92] and 5.09 [2.31-11.22], respectively). | |||||||
| 21886824 | HLA (HLA) | co-infection | NA | NA | NA | unclassified | |
| hiv co-infection and the same hla allele were also associated with indeterminate results (or = 99.59 [95% ci, 15.58-625.61] and 4.25 [1.27-14.16]). | |||||||
| 21886824 | HLA (HLA) | co-infection | NA | NA | NA | unclassified | |
| aging, emaciation, hiv co-infection and hla genotype affected igra results. | |||||||
| 21886824 | HLA (HLA) | emaciation | NA | NA | NA | unclassified | |
| aging, emaciation, hiv co-infection and hla genotype affected igra results. | |||||||
| 24942882 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | co-infection | European | NA | NA | only_studied | |
| three risk factors were identified in this patient: epstein-barr virus reactivation with cytomegalovirus co-infection | |||||||
| 28826735 | HLA (HLA) | co-infection | NA | NA | NA | unclassified | |
| we explored the potential effects of gender, hla type, presence of co-infection, ethnicity, art type, and rate of pre-treatment cd4 decline among cases and controls. | |||||||
| 30803177 | HLA-DR (HLA-DR) | co-infection | NA | NA | NA | positive | |
| meanwhile, neither serum hiv viral load nor serum cmv viral load was correlated with hla-dr(+)cd(8)(+)/cd(8)(+), cd(8)(+)cd(38)(+)/cd(8)(+), cd(4)(+)t cell counts, and cd(4)(+)/cd(8)(+) ratio in the cmv and hiv/aids co-infection group (all p>0.05), while hiv viral load in hiv/aids only group was significantly correlated with hla-dr(+)cd(8)(+)t/cd(8)(+), cd(38)(+)cd(8)(+)/cd(8)(+), cd(4)(+) t cell counts, cd(4)(+)/cd(8)(+) ratio (r=0.473, 0.575, -0.767 and -0.678, respectively, all p<0.05). | |||||||
| 22892080 | HLA-DQB1 (HLA-DQB1) | metabolic syndrome | NA | insulin | NA | unclassified | |
| of all 50 patients, 38% was overweight/obese, 84% had a positive family history of metabolic syndrome, 82% had positive antibodies, and 100% were positive for the high-risk hla-dqb1 genotype. | |||||||
| 22892080 | HLA-DQB1 (HLA-DQB1) | metabolic disease | NA | insulin | NA | only_studied | |
| insulin reserve was evaluated by measuring basal c-peptide and stimulated c-peptide in response to a mixed meal (mmtt) as well as hla-dqb1 genotype, antibodies, and family history of risk factors for metabolic disease. | |||||||
| 27391387 | HLA-B*57 | metabolic syndrome | African | NA | NA | unclassified | |
| predictors of metabolic syndrome were age (per year increase odds ratio (or) = 1.12; 95% ci: 1.07 to 1.16), time postinfection (per year or = 1.47; 95% ci: 1.12 to 1.92), family history of diabetes (or = 3.13; 95% ci: 1.71 to 5.72), and the human leukocyte antigen (hla)-b*81:01 allele (or = 2.95; 95% ci: 1.21 to 7.17), whereas any hla-b*57 or b*58:01 alleles were protective (or = 0.34; 95% ci: 0.15 to 0.77). | |||||||
Copyright 2024